BAROnova® Selected to the Fierce 15
GOLETA, Calif., Oct. 22, 2013 /PRNewswire/ -- BAROnova has been selected by FierceMedicalDevices as one of 2013's Fierce 15 device and diagnostic companies, designating it as one of the most promising private companies in the medtech space. This is FierceMedicalDevices' second annual Fierce 15 selection.
"These companies represent some of the best and brightest in the device and diagnostics industries today," FierceMedicalDevices Editor Mark Hollmer said. "They'll be producing big things in the months ahead."
BAROnova, founded in 2006 and based in Goleta, CA, is a clinical-stage medical-technology company focused on developing non-surgical non-pharmacologic devices to induce weight loss. They recently closed a Series C financing of $27.3 million to continue the clinical development of their innovative TransPyloric Shuttle® device.
"We are extremely pleased to be chosen as one of the Fierce 15," said Hugh Narciso, Founder, President and CEO of BAROnova. "This further validates our technology and the market's need to find a safe and effective solution to fight obesity."
FierceMedicalDevices is an internationally-recognized newsletter that reaches more than 30,000 medical device and diagnostics industry professionals and provides subscribers with an authoritative analysis of the day's top stories. Every year, FierceMedicalDevices evaluates dozens of private companies from around the world for its annual Fierce 15 list, which is based on factors including technology strength, partnerships, venture backers, and a competitive market position. A complete list of the 2013 Fierce 15 companies is available online at FierceMedicalDevices.com.
BAROnova, Inc., contact:
SOURCE BAROnova, Inc.